Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03257254 · ClinicalTrials.gov registry record
Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 76
- Enrollment target
NCT03257254 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 76 participants.
The verdict
NCT03257254 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
A 12 month, multicenter, open-label registry to observe chronic venous insufficiency resulting in VLU treated with Varithena.
Interventions
- DRUG Varithena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2017-09-29 |
| Est. Completion | 2020-09-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03257254
The ClinicalTrials.gov registry entry for NCT03257254 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Varithena is the first listed.
NCT03257254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03257254 about?
NCT03257254 is a clinical study titled "Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)". A 12 month, multicenter, open-label registry to observe chronic venous insufficiency resulting in VLU treated with Varithena.
What is the current status of trial NCT03257254?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2017-09-29. Estimated completion is 2020-09-28.
What interventions are being tested in trial NCT03257254?
The interventions under investigation include: Varithena (DRUG).
Who is sponsoring clinical trial NCT03257254?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.